This workshop provides advanced training for use of liver point-of-care ultrasonography (POCUS). It is intended for professionals who have previously completed the Basic Skills Liver POCUS course at The Liver Meeting or Digestive Disease Week. The workshop includes a theoretical portion focusing on assessment of inpatient liver findings using POCUS, liver elastography, and advice on implementing liver POCUS in clinical practice. A hands-on session follows with an approach to specific liver findings instead of normal liver anatomy. The workshop concludes with a question-and-answer period.

IMPORTANT NOTE: To register for this session, participants must either be registered for the Basic Skills Liver POCUS Workshop at The Liver Meeting 2026 or have previously completed a Basic Skills Liver POCUS Workshop at The Liver Meeting 2025 or Digestive Disease Week 2026.

This workshop introduces the concept of point-of-care ultrasonography (POCUS) of the liver as an extension of the clinical exam to be performed by hepatology clinicians. Presenters provide a rationale for the use of POCUS, the basics of liver ultrasonography, common applications, and a path to implement POCUS in clinical practice. Participants receive hands-on training for performing POCUS examinations of the liver.

Developed by the Patient Advisory Group, this informative session explores the evolution of transplantation (ideal versus less-than-ideal donors) and the impact of machine perfusion on liver transplants. Presenters discuss challenges for long-term transplant survivors including models to inform. The patient perspective is shared with a discussion of mental health challenges, including hepatic encephalopathy, depression, and family discussions. Panelists also touch on transplant access disparities and how patients can overcome them.

Pediatric and rare liver diseases present unique diagnostic, therapeutic, and psychosocial challenges for children and their families. Delayed diagnosis, limited treatment options, fragmented care, and inequitable access to specialty services continue to impact outcomes across the lifespan. Program presenters provide an overview of challenges and solutions, and share a view of what may be in store in the future.

Developed by Patient Advisory Group, this session examines the importance of the patient experience within research and clinical care with a focus on cholestatic liver disease—especially primary sclerosing cholangitis (PSC). Session themes include issues of delayed diagnosis, fragmented care, unmet symptom burdens, and ways to improve the patient experience through better care coordination.

This unique program brings together patients, caregivers, and clinicians to share stories and practical advice about living with liver disease. Caregivers discuss supporting a loved one with liver disease—the emotional ups and downs, stress, and self-care. Panelists address mental health concerns, reducing stigma, effective communication with health care practitioners, and transitioning from pediatric to adult health care. Speakers also highlight dealing with hepatologist desserts and working in rural health care with telehealth. Patients, caregivers, family members, and health care practitioners all stand to gain useful tools and confidence to navigate liver disease together.

Developed by the Patient Advisory Group, this session explores important topics affecting persons living with hepatitis B virus (HBV) infection, including:

• Hepatocellular carcinoma (HCC) surveillance
• New American Association for the Study of Liver Diseases HBV guidelines
• Emerging diseases such as hepatitis D virus and Met-HBV
• Unique challenges of treating chronic hepatitis B and coinfections
• Barriers to surveillance and treatment

Many patients with liver cancer do not receive a referral to a multidisciplinary liver tumor board—especially not in a timely manner. This may result in misdiagnosis, unnecessary diagnostic testing that delays the diagnosis, and/or delayed or failure to initiate recommended treatments.

Presenters explore what multidisciplinary liver tumor boards are and how they streamline the diagnosis and treatment of patients with liver cancer. Key topics include what makes a great multidisciplinary liver tumor board, and why multidisciplinary care is so important in liver cancer. Speakers aim to increase awareness of and access to multidisciplinary liver tumor boards and multidisciplinary care for all persons living with liver cancer.

As liver care becomes increasingly digital, expanded access to medical records, clinical notes, and artificial intelligence (AI)–supported tools is reshaping how patients understand and engage in their care. When integrated thoughtfully, these tools have the potential to improve clarity, support earlier recognition of disease patterns, and enhance patient-clinician communication. At the same time, increased transparency and patient-facing AI tools can introduce complexity. Variability in interpretation, over-reliance on automated insights, and inconsistent digital access may affect how information is understood and discussed in clinical encounters.

The session centers the patient navigation experience within modern hepatology practice. Faculty examine how individuals living with liver disease access and interpret digital health information; what AI–supported diagnostic tools can and cannot reliably provide; and how clinicians and patients can navigate conversations when AI–generated interpretations enter the exam room. Presenters focus particular attention on how these benefits and risks manifest across rural and urban care environments, where differences in infrastructure, specialty access, and digital resources may influence implementation and patient experiences. Speakers aim to provide a balanced, clinically grounded framework for integrating digital transparency and tools into liver disease care while preserving safety and trust.

Join this thought-provoking session which addresses key questions and approaches to overcome social and medical stigma to improve outcomes for persons living with alcohol-associated liver disease (ALD). Utilizing a panel that includes both clinical and patient perspectives, the discussion addresses key topics including:

• How to get the conversation started around alcohol use
• How to address mental health challenges for patients who drink alcohol
• How to talk about changes in ALD treatment
• Reasons why silence/hiding drinking is still so prevalent (not dishonesty but a survival mechanism against social and medical stigma)